| __timestamp | Supernus Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 116287000 | 27632226 |
| Thursday, January 1, 2015 | 136004000 | 97707000 |
| Friday, January 1, 2016 | 203017000 | 129037000 |
| Sunday, January 1, 2017 | 287023000 | 151332000 |
| Monday, January 1, 2018 | 393541000 | 158719000 |
| Tuesday, January 1, 2019 | 376095000 | 170104000 |
| Wednesday, January 1, 2020 | 467938000 | 192195000 |
| Friday, January 1, 2021 | 504714000 | 220706000 |
| Saturday, January 1, 2022 | 580017000 | 204426000 |
| Sunday, January 1, 2023 | 523742000 | 133788000 |
Unleashing insights
In the competitive world of pharmaceuticals, financial performance is a key indicator of success. Over the past decade, Supernus Pharmaceuticals, Inc. has consistently outperformed Travere Therapeutics, Inc. in terms of gross profit. From 2014 to 2023, Supernus saw a remarkable growth, with its gross profit peaking at approximately 580 million in 2022, a staggering 400% increase from 2014. In contrast, Travere's gross profit, while growing, reached its highest at around 220 million in 2021, marking a more modest 700% increase from its 2014 figures.
This financial trajectory highlights Supernus's robust market strategy and operational efficiency. As the pharmaceutical industry continues to evolve, these figures underscore the importance of strategic planning and innovation in maintaining a competitive edge. Investors and industry watchers will be keen to see how these companies adapt to future challenges and opportunities.
Gross Profit Trends Compared: AstraZeneca PLC vs Travere Therapeutics, Inc.
Pfizer Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Bristol-Myers Squibb Company and Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Jazz Pharmaceuticals plc vs Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Amneal Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Perrigo Company plc vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Veracyte, Inc. and Travere Therapeutics, Inc.
Who Generates Higher Gross Profit? Vericel Corporation or Travere Therapeutics, Inc.